ASIA-PACIFIC COUGH SYRUP MARKET 2022-2028

 

 

TABLE OF CONTENTS

1. ASIA-PACIFIC COUGH SYRUP MARKET - SUMMARY

2. INDUSTRY OUTLOOK

2.1. IMPACT OF COVID-19 ON THE COUGH SYRUP MARKET

2.2. KEY INSIGHTS

2.2.1. INCREASING DEMAND FOR HERBAL COUGH SYRUPS

2.2.2. COMPANIES PROVIDE SUGAR-FREE COUGH SYRUPS

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1. THREAT OF NEW ENTRANTS

2.3.2. THREAT OF SUBSTITUTES

2.3.3. BARGAINING POWER OF BUYERS

2.3.4. BARGAINING POWER OF SUPPLIERS

2.3.5. THREAT OF COMPETITIVE RIVALRY

2.4. MARKET ATTRACTIVENESS INDEX

2.5. VENDOR SCORECARD

2.6. KEY MARKET STRATEGIES

2.6.1. MERGERS & ACQUISITIONS

2.6.2. DIVESTITURES

2.7. MARKET DRIVERS

2.7.1. INCREASING CHRONIC RESPIRATORY DISEASES

2.7.2. RISE IN OLDER POPULATION

2.8. MARKET CHALLENGES

2.8.1. OVERDOSE RISK

2.8.2. STRICT GOVERNMENT REGULATIONS AND RESTRICTIONS

2.9. MARKET OPPORTUNITIES

2.9.1. INCREASE IN CHILD-FRIENDLY COUGH SYRUP FLAVORS

2.9.2. GROWING PREFERENCE FOR HOMEOPATHIC COUGH SYRUPS

2.9.3. SPECIAL PEDIATRIC COUGH SYRUPS

3. ASIA-PACIFIC COUGH SYRUP MARKET OUTLOOK - BY PRODUCT TYPE

3.1. COUGH SUPPRESSANTS/ANTITUSSIVES

3.2. COMBINATION MEDICATIONS

3.3. EXPECTORANTS

4. ASIA-PACIFIC COUGH SYRUP MARKET OUTLOOK - BY AGE GROUP

4.1. ADULT

4.2. PEDIATRIC

5. ASIA-PACIFIC COUGH SYRUP MARKET OUTLOOK - BY DISTRIBUTION CHANNEL

5.1. RETAIL PHARMACY

5.2. HOSPITAL PHARMACY

5.3. ONLINE PHARMACY

6. ASIA-PACIFIC COUGH SYRUP MARKET – COUNTRY OUTLOOK

6.1. CHINA

6.2. JAPAN

6.3. INDIA

6.4. SOUTH KOREA

6.5. ASEAN COUNTRIES

6.6. AUSTRALIA & NEW ZEALAND

6.7. REST OF ASIA-PACIFIC

7. COMPETITIVE LANDSCAPE

7.1. ABBOTT LABORATORIES

7.2. ACELLA PHARMACEUTICALS LLC

7.3. ASTRAZENECA PLC

7.4. CIPLA LIMITED

7.5. DABUR INDIA LTD

7.6. GLAXOSMITHKLINE

7.7. GLENMARK PHARMACEUTICALS LIMITED

7.8. JOHNSON AND JOHNSON

7.9. MERCK KGAA

7.10. NOVARTIS INTERNATIONAL AG

7.11. PFIZER INC

7.12. PROCTOR AND GAMBLE CO

7.13. RECKITT BENCKISER GROUP PLC

7.14. SANOFI SA

7.15. THE HIMALAYA DRUG COMPANY

8. RESEARCH METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE & DELIVERABLES

8.2. SOURCES OF DATA

8.3. RESEARCH METHODOLOGY

         

 

LIST OF TABLES

TABLE 1: ASIA-PACIFIC COUGH SYRUP MARKET, BY COUNTRY, 2022-2028 (IN $ MILLION)

TABLE 2: VENDOR SCORECARD

TABLE 3: THE COUNTRIES WITH THE LARGEST PERCENTAGE OF TOTAL POPULATION OVER 65 YEARS IN 2020

TABLE 4: ASIA-PACIFIC COUGH SYRUP MARKET, BY PRODUCT TYPE, 2022-2028 (IN $ MILLION)

TABLE 5: ASIA-PACIFIC COUGH SYRUP MARKET, BY AGE GROUP, 2022-2028 (IN $ MILLION)

TABLE 6: ASIA-PACIFIC COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2022-2028 (IN $ MILLION)

TABLE 7: ASIA-PACIFIC COUGH SYRUP MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

 

 

LIST OF FIGURES

FIGURE 1: MARKET ATTRACTIVENESS INDEX

FIGURE 2: ASIA-PACIFIC COUGH SYRUP MARKET, BY PRODUCT TYPE, 2021 & 2028 (IN %)

FIGURE 3: ASIA-PACIFIC COUGH SYRUP MARKET, BY COUGH SUPPRESSANTS/ANTITUSSIVES, 2022-2028 (IN $ MILLION)

FIGURE 4: ASIA-PACIFIC COUGH SYRUP MARKET, BY COMBINATION MEDICATIONS, 2022-2028 (IN $ MILLION)

FIGURE 5: ASIA-PACIFIC COUGH SYRUP MARKET, BY EXPECTORANTS, 2022-2028 (IN $ MILLION)

FIGURE 6: ASIA-PACIFIC COUGH SYRUP MARKET, BY AGE GROUP, 2021 & 2028 (IN %)

FIGURE 7: ASIA-PACIFIC COUGH SYRUP MARKET, BY ADULT, 2022-2028 (IN $ MILLION)

FIGURE 8: ASIA-PACIFIC COUGH SYRUP MARKET, BY PEDIATRIC, 2022-2028 (IN $ MILLION)

FIGURE 9: ASIA-PACIFIC COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2021 & 2028 (IN %)

FIGURE 10: ASIA-PACIFIC COUGH SYRUP MARKET, BY RETAIL PHARMACY, 2022-2028 (IN $ MILLION)

FIGURE 11: ASIA-PACIFIC COUGH SYRUP MARKET, BY HOSPITAL PHARMACY, 2022-2028 (IN $ MILLION)

FIGURE 12: ASIA-PACIFIC COUGH SYRUP MARKET, BY ONLINE PHARMACY, 2022-2028 (IN $ MILLION)

FIGURE 13: ASIA-PACIFIC COUGH SYRUP MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)

FIGURE 14: CHINA COUGH SYRUP MARKET 2022-2028 (IN $ MILLION)

FIGURE 15: JAPAN COUGH SYRUP MARKET 2022-2028 (IN $ MILLION)

FIGURE 16: INDIA COUGH SYRUP MARKET 2022-2028 (IN $ MILLION)

FIGURE 17: SOUTH KOREA COUGH SYRUP MARKET 2022-2028 (IN $ MILLION)

FIGURE 18: ASEAN COUNTRIES COUGH SYRUP MARKET 2022-2028 (IN $ MILLION)

FIGURE 19: AUSTRALIA & NEW ZEALAND COUGH SYRUP MARKET 2022-2028 (IN $ MILLION)

FIGURE 20: REST OF ASIA-PACIFIC COUGH SYRUP MARKET 2022-2028 (IN $ MILLION)

 

 

MARKET OUTLOOK

Triton Market Research’s report on the Asia-Pacific cough syrup market insinuates that the market is anticipated to advance at a CAGR of 3.69% in revenue during the forecasting period 2022-2028. Australia & New Zealand, China, India, South Korea, Japan, ASEAN countries, and Rest of APAC outline the market in the considered region.

In Japan, the rise in the aging population has resulted in an increase in patients suffering from pneumonia, respiratory failure, lung cancer, obstructive pulmonary disease, and asthma. In recent years, lung cancer has become highly prevalent in the nation, causing the highest mortality. Furthermore, chronic respiratory diseases have surged substantially due to various environmental factors, especially air pollution. Therefore, the rise in respiratory diseases, surged pollution levels, and the increased elderly population are prominent factors boosting the cough syrup market’s growth.

Similarly, India faces a high burden of chronic respiratory diseases, particularly asthma and chronic obstructive pulmonary disease. COPD accounts for nearly a million deaths each year across the country. Furthermore, the rise in population has resulted in increased adoption of vehicles, construction of new housing and public infrastructure, and construction of new roads. This has significantly increased pollution levels in the nation, causing various respiratory issues. Therefore, as mentioned above, these factors increase the demand for cough syrup, propelling the cough syrup market on a progressive path.

 

 

COMPETITIVE OUTLOOK

The major players in the cough syrup market are Abbott Laboratories, Dabur India Ltd, AstraZeneca Plc, Pfizer Inc, Sanofi SA, Cipla Limited, and Acella Pharmaceuticals LLC.

 

Get more Insights into the Asia-Pacific Cough Syrup Market:

 

https://www.tritonmarketresearch.com/reports/asia-pacific-cough-syrup-market

 

 

SEGMENTATION

1.     ABBOTT LABORATORIES

2.     ACELLA PHARMACEUTICALS LLC

3.     ASTRAZENECA PLC

4.     CIPLA LIMITED

5.     DABUR INDIA LTD

6.     GLAXOSMITHKLINE

7.     GLENMARK PHARMACEUTICALS LIMITED

8.     JOHNSON AND JOHNSON

9.     MERCK KGAA

10. NOVARTIS INTERNATIONAL AG

11. PFIZER INC

12. PROCTOR AND GAMBLE CO

13. RECKITT BENCKISER GROUP PLC

14. SANOFI SA

15. THE HIMALAYA DRUG COMPANY